Search
for
Sort by
Research 481–510 of 1000+
- Targeting of Smoothened for therapeutic gain
- Impact of a Novel Dehydroepiandrosterone Derivative on the Metabolism of RWPE-1 and LNCaP Cell Lines
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Minoxidil may suppress androgen receptor-related functions
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Clinicopathologic and molecular characterization of a series of sporadic trichoblastic neoplasms
- A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats
- Abstract 2205: KRTAP 2-3 is a novel potential biomarker of cells in the polyaneuploid cancer cell (PACC) state to predict cancer recurrence
- Highlights of This Issue
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia
- Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine
- Basic Scientists Investigate Biochemical Basis of Ancient Chinese Medicines
- Editorial Comment
- Pharmacology and Potential Use of Cyproterone Acetate
- This Month in Clinical Urology
- Tracing the cellular origin of cancer
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Androgens in SARS-CoV-2 Coronavirus Infections
- Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Structural perspectives on the androgen receptor, the elusive shape-shifter